SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?


To: FNS who wrote (840)11/23/1998 5:57:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 965
 
Today's WSJ has more on CNTO "Dear Dr" letter on Remicade side effects. Details linked to TNF Inhibitor table on the New Therapeutics page at biocognizance.com
webf2179.ntx.net may be faster



To: FNS who wrote (840)11/23/1998 9:30:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 965
 
BancBoston Robertson Stephens lowered CNTO to Long Term Attractive
today (and lowered earnings for 1998 and 1999). Details linked to New Therapeutics page (TNF Inhibitor table) at biocognizance.com
(http://webf2179.ntx.net may be faster).